优势价格
快速发货
品质保证
技术支持
400-920-2911 sales@csnpharm.cn
| 货号 | 产品名 | CAS号 | 信息 |
|---|---|---|---|
| CSN22537 | α-2,3-sialyltransferase-IN-1 | 881179-06-2 | α-2,3-sialyltransferase-IN-1 is a noncompetitive α-2,3-sialyltransferase inhibitor with an IC50 of 6 μM. |
| CSN22534 | 20-HEDE | 240427-90-1 | WIT 002 is an antagonist of 20-hydroxyeicosatetraenoic acid (20-HETE). |
| CSN22187 | W-2429 | 37795-69-0 | W-2429 is a non-narcotic analgesic agent. |
| CSN22531 | Valemetostat | 1809336-39-7 | Valemetostat is an antineoplastic agent. |
| CSN22525 | Troxacitabine | 145918-75-8 | Troxacitabine is nucleoside analog with potent anticancer activity. |
| CSN22524 | Trombodipine | 113658-85-8 | Trombodipine is an antithrombotic agent. |
| CSN22514 | Tak-778 | 180185-61-9 | TAK-778 is a derivative of ipriflavone and has been shown to induce bone growth in in vitro and in vivo models. |
| CSN22205 | TAK-024 | 186971-69-7 | TAK-024 is a platelet inhibitor with IC50s of 31, 79 and 51 nM in human, monkey and guinea pig, respectively. |
| CSN22246 | TA-7552 | 104756-72-1 | TA-7552 is a potent cholesterol-lowering agent. |
| CSN22512 | SPL-707 | 2195361-33-0 | SPL-707 is a potent, selective and orally available signal peptide peptidase-like 2a (SPPL2a) inhibitor with an IC50 of 80 nM. |
| CSN22509 | SNT-207707 | 1064662-40-3 | SNT-207707 is a selective, potent and orally active melanocortin MC-4 receptor antagonist with an IC50 of 8 nM (binding) and 5 nM (function) on the MC-4 receptor. |
| CSN22499 | Ropidoxuridine | 93265-81-7 | Ropidoxuridine is an orally available, halogenated thymidine analog and is a potential radiosensitizer for use in human tumors. |
| CSN22496 | RH1 | 221635-42-3 | RH1 is a potent bioreductive agent with profound anti-cancer activity in vitro and in vivo. |
| CSN22479 | Padsevonil | 1294000-61-5 | Padsevonil is a potent antiepileptic agent. |
| CSN22474 | Octaaminocryptand 1 | 135469-17-9 | Octaaminocryptand 1 is an aminocryptand ligand. |
| CSN22586 | endo-8-Azabicyclo[3.2.1]octan-3-ol hydrochloride | 14383-51-8 | Nortropeno HCl is a secondary metabolite of tropine derivative drugs, such as atropine and benztropine. |
| CSN22450 | Lurasidone Metabolite 14283 HCl | 186204-32-0 | Lurasidone Metabolite 14283 HCl is a major active metabolite of Lurasidone. Lurasidone is a FDA approved drug for the treatment of schizophrenia. |
| CSN22448 | Lith-O-Asp | 881179-02-8 | Lith-O-Asp is a sialytransferase (ST) inhibitor, with IC50s of 12-37 μM. |
| CSN22184 | L-Pyrrolysine | 448235-52-7 | L-Pyrrolysine is the 22nd genetically encoded amino acid |
| CSN22438 | Rilematovir | 1383450-81-4 | JNJ-53718678 is a novel fusion protein inhibitor in clinical trials for the treatment of respiratory syncytial virus. |
| CSN22429 | BAY 59-9435 | 654059-21-9 | HSL-IN-2 is a potent and selective inhibitor of Hormone Sensitive Lipase (HSL), with an IC50 of 0.023±0.017 μM. |
| CSN22415 | Glutaminyl Cyclase Inhibitor 1 | 2110449-60-8 | Glutaminyl Cyclase Inhibitor 1 is a glutaminyl cyclase inhibitor with an IC50 of 0.5 μM. |
| CSN22414 | GLUFOSFAMIDE | 132682-98-5 | Glufosfamide is a novel alkylating agent in which the active metabolite of isophosphoramide mustard is glycosidically linked to β-D-glucose |
| CSN22410 | GF 15 | 888042-13-5 | GF 15 is a potent inhibitor of centrosomal clustering in tumor cells. |
| CSN22402 | Fodipir | 118248-91-2 | Fodipir is an active metabolite of mangafodipir, involved in mangafodipir-mediated cytoprotection against 7β-hydroxycholesterol-induced cell death. |
| CSN22398 | ETA antagonist 1 | 161801-60-1 | ETA antagonist 1 is a ETA selective antagonist with an IC50 of 0.08 μM. |
| CSN22584 | Eperisone HCl | 56839-43-1 | Eperisone HCl has very low bioavailability after oral administration in rats and extensively high oral clearance in humans. It undergoes extensive first-pass metabolism after oral administration in rats and humans because absorption of the drug is very high. The bioavailabilities in the intestine were 0.176 and 0.0879 at administration rates of 100 and 25 mg/h/kg, respectively, whereas those in the liver were 0.532 and 0.486, respectively. Eperisone has high metabolic clearance in the small intestine. |
| CSN22217 | Emtricitabine S-oxide | 152128-77-3 | Emtricitabine Degradant-III is a major degradation product of Emtricitabine. Emtricitabine is a potent nucleoside reverse transcriptase inhibitor used for the treatment of HIV infection |
| CSN22391 | EC-17 disodium salt | 910661-33-5 | EC-17 (disodium salt) is a folate receptor alpha (FRα) targeting contrast agent with fluorescent properties in the visible light spectrum. The peak excitation and emission wavelengths of EC-17 are 470/520 nm. |
| CSN22387 | Diphenylterazine | 344940-63-2 | Diphenylterazine is a bioluminescence agent. |
| CSN22591 | Dihydralazine sulfate | 7327-87-9 | Dihydralazine Sulfate can be used as an antihypertensive drug. |
| CSN22384 | Dansyl glutathione | 75017-02-6 | Dansyl glutathione is a trapping agent for the quantitative estimation and identification of reactive metabolites. |
| CSN22381 | Elacytarabine | 188181-42-2 | CP 4055 (Elacytarabine) is a lipid-conjugated derivative of the nucleoside analog cytarabine. CP 4055 is an antineoplastic drug with cytotoxicity in solid tumors. |
| CSN22374 | Ci-943 | 89239-35-0 | CI-943 is a potential antipsychotic agent. |
| CSN22570 | Carbasalate calcium | 5749-67-7 | Carbasalate Calcium is an analgesic, antipyretic, and anti-inflammatory drug, as well as a platelet aggregation inhibitor. It is a chelate of calcium acetylsalicylate (the calcium salt of aspirin) and urea. |
| CSN22593 | Bromisoval | 496-67-3 | Bromisoval is a hypnotic and sedative of the bromoureide group |
| CSN22361 | BRCA1-IN-1 | 1622262-74-1 | BRCA1-IN-1 is a novel small-molecule-like BRCA1 inhibitor with IC50 and Ki of 0.53 μM and 0.71 μM, respecrively. |
| CSN22350 | Arterolane | 664338-39-0 | Arterolane is an antimalarial agent, with IC50 of both 1.1 nM against P. falciparum Ro73 and W2, respectively. |
| CSN22256 | Artemisic acid | 80286-58-4 | Artemisic acid is a sesquiterpene that can decrease glycerol-3-phosphate dehydrogenase (GPDH) activity in hAMSCs. It is major precursor of artemisinin. |
| CSN22340 | Afegostat | 169105-89-9 | Afegostat was previously in phase II clinical trials for the treatment of Gaucher's disease. The experiment was discontinued. |
| CSN22334 | Acetylhydrolase-IN-1 | 79637-91-5 | Acetylhydrolase-IN-1 is a 1-Alkyl-2-acetylglycerophosphocholine esterase (Alkylacetyl-GPC: acetylhydrolase) inhibtor. |
| CSN22319 | Dihydrouracil | 504-07-4 | 5,6-Dihydrouracil is an intermediate of uracil catabolism. |
| CSN22314 | 4-Methylbenzylidene camphor | 36861-47-9 | 4-Methylbenzylidene camphor is an ultraviolet light blocker used in cosmetics and sunscreen preparations, it also has estrogenic activities. |
| CSN22330 | RP 54275 | 81364-78-5 | 2-Octadecyl-1H-indole-5-carboxylic acid is a novel hypocholesterolaemic drug. |
| CSN22328 | 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine | 1069-79-0 | 1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine (DSPE) is a phosphoethanolamine (PE) lipid that can be used in the synthesis of liposomes. |
| CSN22326 | (±)-ANAP | 1185251-08-4 | (±)-ANAP is the unnatural amino acid analog of prodan, acts as a fluorescent probes, and enhances environmental sensitivity. |
| CSN22327 | (9Z,11E)-Prodlure | 50767-79-8 | (9Z,11E)-Tetradecadien-1-yl acetate is the main component of the sex pheromone of female Spodoptera littoralis. |
| CSN22322 | (-)-Ketoconazole | 142128-57-2 | (-)-Ketoconazole is one of the enantiomer of Ketoconazole. Ketoconazole is a racemic mixture of two enantiomers, levoketoconazole ((2S,4R)-(−)-ketoconazole) and dextroketoconazole ((2R,4S)-(+)-ketoconazole). |
| CSN22215 | Boc-Dap-NE | 160800-65-7 |
